These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24602087)

  • 1. Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study.
    Dunstan HJ; Mill AC; Stephens S; Yates LM; Thomas SH
    BJOG; 2014 Jun; 121(7):901-6. PubMed ID: 24602087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009.
    Saito S; Minakami H; Nakai A; Unno N; Kubo T; Yoshimura Y
    Am J Obstet Gynecol; 2013 Aug; 209(2):130.e1-9. PubMed ID: 23583838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
    Svensson T; Granath F; Stephansson O; Kieler H
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1030-4. PubMed ID: 21774030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
    Heneghan CJ; Onakpoya I; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Mahtani KR; Nunan D; Howick J; Jefferson T
    Health Technol Assess; 2016 May; 20(42):1-242. PubMed ID: 27246259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influenza A, pregnancy and neuraminidase inhibitors].
    Montané E; Lecumberri J; Pedro-Botet ML
    Med Clin (Barc); 2011 May; 136(15):688-93. PubMed ID: 20416906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.
    Donner B; Niranjan V; Hoffmann G
    Drug Saf; 2010 Aug; 33(8):631-42. PubMed ID: 20635821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants.
    Chambers CD; Johnson D; Xu R; Luo Y; Jones KL;
    Birth Defects Res; 2019 Nov; 111(19):1487-1493. PubMed ID: 31397112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
    Doshi S; Kamimoto L; Finelli L; Perez A; Reingold A; Gershman K; Yousey-Hindes K; Arnold K; Ryan P; Lynfield R; Morin C; Baumbach J; Hancock EB; Bennett NM; Zansky S; Thomas A; Schaffner W; Fry AM
    J Infect Dis; 2011 Dec; 204(12):1848-56. PubMed ID: 22013219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).
    Chan-Tack KM; Kim C; Moruf A; Birnkrant DB
    Antivir Ther; 2015; 20(5):561-4. PubMed ID: 25667992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic.
    Xie HY; Yasseen AS; Xie RH; Fell DB; Sprague AE; Liu N; Smith GN; Walker MC; Wen SW
    Am J Obstet Gynecol; 2013 Apr; 208(4):293.e1-7. PubMed ID: 23333544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson T; Jones M; Doshi P; Del Mar C; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2010 Feb; 2011(2):CD001265. PubMed ID: 20166059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    PLoS One; 2012; 7(9):e43491. PubMed ID: 22984431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
    Yates L; Pierce M; Stephens S; Mill AC; Spark P; Kurinczuk JJ; Valappil M; Brocklehurst P; Thomas SH; Knight M
    Health Technol Assess; 2010 Jul; 14(34):109-82. PubMed ID: 20630123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment.
    Tuna N; Karabay O; Yahyaoğlu M
    Indian J Pharmacol; 2012; 44(6):780-3. PubMed ID: 23248411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.